Several companies have already announced the brands they will launch, like Natco Pharmaceuticals, which will launch Semanat and Semafull in 2mg, 4mg, and 8mg doses
Observational studies show reduced risk of major cardiovascular events, kidney outcomes, and death
A recent poll shows that 12% of Americans reported having taken these medicines
The NHS advises that individuals seeking weight loss should focus on evidence-based approaches, including reducing calorie intake, increasing physical activity, and accessing support through services such as the NHS Weight Loss Plan or local weight management programmes
As the condition progresses, the pain becomes persistent and increasingly severe, lasting for several days
While Wegovy has been FDA-approved for weight loss, users may experience side effects